Skip to main content

Bridge Capital Provides $7M Line of Credit for Fluidigm

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bridge Capital Holdings and its subsidiary Bridge Bank National Association said after the close of the market on Thursday that they have provided Fluidigm with a $7 million line of credit.

The credit line was originally established in December 2010, when it was set at $4 million, according to a document filed with the US Securities and Exchange Commission in January.

The South San Francisco, Calif.-based company, which develops microfluidic systems for the life sciences and agricultural biotechnology industries, went public in February. Fluidigm CFO Vikram Jog said today that the financing will provide the company with greater flexibility to manage its working capital.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.